Inactive Instrument

Press Releases Novavax, Inc. Nasdaq

Equities

US6700021040

Press Releases

Unlock all the news: Be the first to know and act before the market!

Novavax - U.S. CDC and ACIP Recommend Use of Authorized and Approved 2024-2025 COVID-19 Vaccines	28/06	AQ
Novavax : U.S. ACIP Recommends Use of Authorized and Approved 2024 2025 COVID 19 Vaccines	28/06	PU
Intelligent Bio Solutions Inc. (NASDAQ: INBS) Rises in After-Hours Trading Following Major UK Contracts and FDA Progress	27/06	AQ
Novavax Submits Application to European Medicines Agency for Updated Protein-based 2024-2025 Formula COVID-19 Vaccine	24/06	PR
Peraso Inc. (NASDAQ: PRSO) Director Invests $127K, Ladenburg Thalmann Coverage, Gains Bullish Momentum	20/06	AQ
Catheter Precision (NYSE American: VTAK) Announces New LockeT Purchase Order and Expands Sales Team Amid Surge in Trading Volume	19/06	AQ
Novavax Submits Application to U.S. FDA for Updated Protein-based 2024-2025 Formula COVID-19 Vaccine	17/06	AQ
Novavax Submits Application to U.S. FDA for Updated Protein-based 2024-2025 Formula COVID-19 Vaccine	14/06	PR
Novavax Prepared to Deliver JN.1 Protein-based Non-mRNA COVID-19 Vaccine This Fall Consistent with U.S. FDA VRBPAC Recommendation	06/06	AQ
Peraso Inc. (NASDAQ: PRSO) Announces Paradigm-Shifting mmWave Wi-Fi Advancements with Phased Array Antenna Technology	06/06	AQ
FDA advisers urge targeting JN.1 strain in recipe for fall's COVID vaccines	06/06	AQ
Novavax : Prepared to Deliver JN.1 Protein based Non mRNA COVID 19 Vaccine This Fall Consistent with U.S. FDA VRBPAC Recommendation	06/06	PU
Dyadic International Inc. (DYAI): Bird Flu Vaccine Development Amid Rising Pandemic Concerns	30/05	AQ
Novavax to Participate in 2024 Jefferies Global Healthcare Conference	30/05	PR
Serum Institute of India Ships Its First Set of R21/Matrix-M? Malaria Vaccine Doses to Africa [press release]	20/05	AQ
Shah Capital Withdraws Proxy Campaign Against Re-Election of Directors at Novavax’s 2024 Annual Meeting	20/05	AQ
Novavax to Participate in BofA Securities 2024 Health Care Conference	14/05	PR
Sanofi and Novavax announce co-exclusive licensing agreement to co-commercialize COVID-19 vaccine and develop novel flu-COVID-19 combination vaccines	13/05	AQ
Novavax Reports First Quarter 2024 Financial Results and Operational Highlights	13/05	AQ
Q1 2024 Earnings presentation	10/05	PU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

Novavax Surges on $1.2 Billion Sanofi Vaccine Deal

May 11, 2024 at 12:22 am IST